DiaMedica Therapeutics Inc. (DMAC)

DiaMedica Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	15.65	3.03	4.54	4.73	4.71
Short-Term Investments	44.24	41.12	48.35	28.77	40.41
Cash & Short-Term Investments	59.89	44.15	52.9	33.5	45.11
Cash Growth	35.66%	-16.54%	57.89%	-25.74%	64.00%
Accounts Receivable	0.26	0.24	0.37	0.08	0.13
Other Current Assets	0.48	0.23	0.41	0.25	0.2
Total Current Assets	60.63	44.61	53.68	33.84	45.44
Net Property, Plant & Equipment	0.34	0.43	0.49	0.56	0.11
Other Long-Term Assets	0.4	1.31	-	-	-
Total Assets	61.37	46.35	54.16	34.4	45.55
Accounts Payable	1.48	0.94	0.93	0.73	0.51
Accrued Expenses	3.55	4.35	1.78	1.37	0.97
Current Portion of Leases	0.11	0.1	0.08	0.07	0.05
Total Current Liabilities	5.13	5.39	2.79	2.17	1.52
Long-Term Leases	0.13	0.24	0.32	0.4	0
Total Long-Term Liabilities	0.13	0.24	0.32	0.4	0
Total Liabilities	5.26	5.63	3.1	2.57	1.53
Additional Paid-in Capital	228.83	180.7	166.61	128.08	126.58
Accumulated Other Comprehensive Income	0.05	0.02	0.01	-0.07	-0.05
Retained Earnings	-172.77	-140	-115.56	-96.18	-82.5
Shareholders' Equity	56.11	40.72	51.06	31.83	44.02
Total Liabilities & Equity	61.37	46.35	54.16	34.4	45.55
Total Debt	0.24	0.34	0.4	0.47	0.05
Net Cash (Debt)	59.65	43.81	52.5	33.03	45.06
Net Cash Growth	36.17%	-16.55%	58.92%	-26.69%	64.52%
Net Cash Per Share	1.27	1.08	1.61	1.25	2.17
Book Value	56.11	40.72	51.06	31.83	44.02
Book Value Per Share	1.19	1.01	1.57	1.20	2.12
Tangible Book Value	56.11	40.72	51.06	31.83	44.02
Tangible Book Value Per Share	1.19	1.01	1.57	1.20	2.12

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q